- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:12 | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 13:06 | Pulsenmore Ltd.: Pulsenmore Expands Its Fertility Platform into the UK | 209 | PR Newswire | MHRA registration allows Pulsenmore FC to be marketed across the United Kingdom and Northern Ireland, extending the Company's home ultrasound platform into the UK fertility market where more than... ► Artikel lesen | |
| PULSENMORE Aktie jetzt für 0€ handeln | |||||
| 08.09. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 08.09. | Pulsenmore Ltd.: Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring | 139 | PR Newswire | The Pulsenmore FC system is designed to enable women undergoing IVF and fertility preservation treatments to self-perform ultrasound scans from home This registration marks the Company's... ► Artikel lesen | |
| 31.08. | Pulsenmore Ltd. reports 1H results | 3 | Seeking Alpha | ||
| 31.08. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 31.08. | Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026 | 258 | PR Newswire | Management to Host Webcast today at 8:30 am ET to discuss Results and Provide Business Update
OMER, Israel, Aug. 31, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:... ► Artikel lesen | |
| 19.08. | Pulsenmore expands home ultrasound service to Ichilov hospital | 1 | Investing.com | ||
| 17.08. | Pulsenmore receives $1.27M grant for AI ultrasound program | 1 | Investing.com | ||
| 17.08. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 13.07. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 02.07. | Pulsenmore Ltd. - F-1, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 01.07. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 25.06. | Pulsenmore raises $7.5M in private placement; shares down | 1 | Seeking Alpha | ||
| 25.06. | Pulsenmore raises $7.5 million in private placement | 1 | Investing.com | ||
| 24.06. | Pulsenmore partners with Ouma Health for home ultrasound care | 1 | Investing.com | ||
| 24.06. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 24.06. | Pulsenmore Ltd.: Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States | 351 | PR Newswire | FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care model, creating a scalable pathway to expand the adoption of home ultrasound in prenatal... ► Artikel lesen | |
| 12.06. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.05. | Pulsenmore Ltd. - 6-K, Report of foreign issuer | - | SEC Filings |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 8,710 | 0,00 % | Alignment Healthcare extends retreat, falls an additional 16% | ||
| BETA BIONICS | 22,180 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,790 | 0,00 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | ||
| AVEANNA HEALTHCARE | 14,260 | 0,00 % | Aveanna Healthcare auf dem Deutsche Bank Healthcare Summit 2026: Neuausrichtung auf Wachstumskurs | ||
| BRIGHTSPRING HEALTH SERVICES | 58,97 | +0,02 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| GENEDX | 97,48 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| HEARTFLOW | 48,330 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| FRESENIUS | 46,150 | +0,02 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
10.09.2026 / 11:59... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,540 | +0,47 % | BERENBERG stuft Siemens Healthineers auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat Siemens Healthineers mit einem Kursziel von 40 Euro auf "Hold" belassen. Der Medizintechnik- und Life-Science-Sektor bleibe fundamental attraktiv... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,770 | -0,65 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 19,450 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BILLIONTOONE | 103,51 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,360 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,210 | 0,00 % | Tempest Therapeutics: Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform | -Transaction complements Tempest's existing CD7-targeted lipid nanoparticle in vivo CAR-T delivery platform, which is planned to enter the clinic later this year -Lead BCMA/GPRC5D dual-targeting in... ► Artikel lesen | |
| PROGYNY | 27,390 | +0,04 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen |
Das Unternehmen PULSENMORE LTD kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,410 Euro und damit +2,99 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PULSENMORE LTD finden Sie auf Wallstreet Online.